This program is designed to provide the foundational
knowledge and approach / coordination for integrating the patient perspective
into the full medicines lifecycle, including regulatory decision making and
post-marketing efforts, which can improve patient outcomes and increase the
success of the product.
Who is the target audience?
It is designed for professionals involved in Patient
Advocacy, Patient Engagement, Patient Experience and Access
What am I going to get from this course?
- Describe the investigational product development process
Review Regulatory Authorities (FDA, EMEA, MOHs, etc.) regulations and the ICH GCP E6 Guideline for Good Clinical Practices (GCP)
Describe the roles and responsibilities of the Clinical Research Coordinator (CRC) before, during and after a clinical trial
Identify the requirements of the Investigator (PI, CoI / Sub-I) in supervising clinical research
Discuss the role of an Institutional Review Board (IRB) / Independent Ethics Committee (IEC), its composition and responsibilities in the clinical trial process
Define the informed consent process and the elements of the informed consent document
Define source documents and Case Report Forms (CRFs) in relation to CRF completion and Source Document / Data Verification (SDV)
Describe definitions related to safety management, identification of adverse events and reporting requirements